GlassScriptPhysician profile
Elizabeth Munro
NPI 1508838897
$8,228.78
in general payments reported to CMS, 2019-2025
5 companies · $7,958 in 2025
The $7,958 reported for 2025 was more than what 89% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.94 · 2022: $20.86 · 2023: $153 · 2024: $69.00 · 2025: $7,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,675 · Education: $1,090 · Travel and Lodging: $975 · Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,675.00 |
| Education | $1,090.20 |
| Travel and Lodging | $974.65 |
| Food and Beverage | $440.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $6,553.13 | 2025 | Korlym |
| Intuitive Surgical, INC. | $1,536.65 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $74.50 | 2019-2025 | Keytruda |
| Glaxosmithkline, LLC. | $64.50 | 2024 | Zejula |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Munro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.